Pharmaceutical firms rake in billions with Covid19 jabs
Covid vaccines have brought billions of dollars to the coffers of pharmaceutical companies.
BioNTech reported on Tuesday revenues of $7.3 billion euros in the first half. Unlike its larger partner, the company's only product on sale is the coronavirus vaccine. Messenger RNA technology works by providing human cells with the genetic instructions to make a surface protein of the coronavirus, which trains the immune system to recognise the real virus.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 LIVE UPDATES | UK PM Johnson won't isolate after staff member's positive Covid testCoronavirus updates.
Read more »
No need yet to adapt Pfizer vaccine for Covid-19 variants: BioNTech chiefBioNTech-Pfizer’s first generation vaccine works against Covid-19 variants like the Delta strain and does not need to be modified at the moment, a company executive said.
Read more »
WOMEN’S DAY | 'Now I know I'll never crack under pressure': Ramathuba on managing Covid-19 response“When I had my first child‚ I wasn’t married. My mother asked me when I was getting married after I got my degree and my father defended me.” She recounted how he used to say “her husband is a degree”.
Read more »
Botswana: ‘Masisi is mismanaging Covid-19’ - The Mail & GuardianIn early May, President Mokgweetsi Masisi told a CNN journalist that Botswana is “on the verge” of becoming the first African country to vaccinate its entire adult population against the deadly Covid-19.
Read more »
COVID-19 epidemic eases in parts of DR CongoCongolese authorities said Sunday the coronavirus epidemic had eased in many parts of the country but remained worrying in the economic capital of Lumbubashi
Read more »